The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non‐small cell lung cancer

The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non‐small cell lung cancer

Abstract Background CT scans are used in routine clinical practice for the diagnosis and treatment surveillance of non‐small cell lung cancer (NSCLC). However, more sensitive methods are desirable. Liquid biopsy analyses of RNA and DNA can offer more sensitive diagnostic approaches. Cell‐free RNA (c...

Full description

Bibliographic Details
Main Authors: Martin Metzenmacher, Balazs Hegedüs, Jan Forster, Alexander Schramm, Peter A. Horn, Christoph A. Klein, Nicola Bielefeld, Till Ploenes, Clemens Aigner, Jens T. Siveke, Martin Schuler, Smiths S. Lueong
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Thoracic Cancer
Subjects:
cfRNA
ddPCR
liquid biopsy
NGS
NSCLC
Online Access:https://doi.org/10.1111/1759-7714.14540

Internet

https://doi.org/10.1111/1759-7714.14540

Similar Items